Cargando…
Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland
The present multi-center, long-term, real-life study made an attempt to assess the efficacy of risankizumab in the treatment of moderate-to-severe plaque psoriasis. The study comprised 185 patients from 10 Polish dermatologic departments undergoing risankizumab treatment. The disease severity was me...
Autores principales: | Adamczyk, Michał, Bartosińska, Joanna, Raczkiewicz, Dorota, Adamska, Kinga, Adamski, Zygmunt, Czubek, Maria, Kręcisz, Beata, Kłujszo, Elżbieta, Lesiak, Aleksandra, Narbutt, Joanna, Noweta, Marcin, Owczarczyk-Saczonek, Agnieszka, Owczarek, Witold, Reich, Adam, Samotij, Dominik, Siekierko, Aleksandra, Szczęch, Justyna, Walecka, Irena, Ciechanowicz, Piotr, Woźniacka, Anna, Liszewska, Agata, Krasowska, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959800/ https://www.ncbi.nlm.nih.gov/pubmed/36836209 http://dx.doi.org/10.3390/jcm12041675 |
Ejemplares similares
-
Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022) -
The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis
por: Kisielnicka, Anna, et al.
Publicado: (2022) -
Novel Application of Light-Emitting Diode Therapy in the Treatment of Eyebrow Loss in Frontal Fibrosing Alopecia
por: Gerkowicz, Agnieszka, et al.
Publicado: (2021) -
The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023) -
IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
por: Michalak-Stoma, Anna, et al.
Publicado: (2020)